Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Northern Trust
NTRS
$34.8B
| $8.77M | 0.01% |
97,398
+72,300
| +288% | +$6.66M |
|
|
AEGN
1502
DELISTED
Aegion Corp
AEGN
| $8.74M | 0.01% |
475,200
-66,600
| -12% | -$1.13M |
|
1503
CTS Corp
CTS
$1.79B
| $8.74M | 0.01% |
316,800
+163,200
| +106% | +$4.7M |
|
|
CBD
1504
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $8.73M | 0.01% |
356,600
+36,000
| +11% | +$818K |
|
|
AQUA
1505
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $8.71M | 0.01% |
611,900
+489,500
| +400% | +$6.36M |
|
|
HUD
1506
DELISTED
Hudson Ltd. Class A Common Shares
HUD
| $8.71M | 0.01% |
631,600
+246,900
| +64% | +$3.61M |
|
|
PZN
1507
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $8.71M | 0.01% |
1,013,700
+57,800
| +6% | +$523K |
|
1508
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.78B
| $8.71M | 0.01% |
86,700
+21,904
| +34% | +$2.19M |
|
|
MTSC
1509
DELISTED
MTS Systems Corp
MTSC
| $8.7M | 0.01% |
148,600
-21,500
| -13% | -$1.2M |
|
1510
Gran Tierra Energy
GTE
$332M
| $8.68M | 0.01% |
545,616
+57,516
| +12% | +$1.23M |
|
1511
Columbus McKinnon
CMCO
$549M
| $8.63M | 0.01% |
205,585
+55,555
| +37% | +$2.11M |
|
1512
Victory Capital Holdings
VCTR
$7.24B
| $8.62M | 0.01% |
501,963
+146,252
| +41% | +$2.41M |
|
1513
Cannae Holdings
CNNE
$681M
| $8.62M | 0.01% |
297,400
-256,400
| -46% | -$6.76M |
|
1514
St. Joe Company
JOE
$3.93B
| $8.62M | 0.01% |
498,800
+196,100
| +65% | +$3.29M |
|
1515
Yelp
YELP
$1.31B
| $8.62M | 0.01% |
252,100
-261,000
| -51% | -$9.03M |
|
1516
Graham Corp
GHM
$1.3B
| $8.61M | 0.01% |
426,157
+25,504
| +6% | +$524K |
|
|
TEN
1517
Tsakos Energy Navigation Ltd
TEN
$1.24B
| $8.6M | 0.01% |
522,520
+38,040
| +8% | +$611K |
|
1518
Xylem
XYL
$28.2B
| $8.56M | 0.01% |
+102,300
| New | +$8.15M |
|
1519
Gildan
GIL
$10.6B
| $8.55M | 0.01% |
220,600
+30,000
| +16% | +$1.12M |
|
1520
The GEO Group
GEO
$4.03B
| $8.5M | 0.01% |
404,700
+70,600
| +21% | +$1.49M |
|
1521
Equity Bancshares
EQBK
$1.06B
| $8.5M | 0.01% |
318,800
-35,800
| -10% | -$955K |
|
1522
RH
RH
$3.45B
| $8.5M | 0.01% |
+73,500
| New | +$7.58M |
|
1523
E.W. Scripps
SSP
$313M
| $8.44M | 0.01% |
551,900
-1,783
| -0.3% | -$33.4K |
|
1524
Citizens Financial Group
CFG
$31.2B
| $8.42M | 0.01% |
238,000
+228,400
| +2,379% | +$7.96M |
|
1525
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
| $8.38M | 0.01% |
156,878
+139,678
| +812% | +$7.38M |
|
Similar funds
Jim Simons's Q2 2019 Portfolio in Review
As of Q2 2019, Jim Simons held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Jim Simons's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Jim Simons added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Jim Simons's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Jim Simons fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Jim Simons's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Jim Simons opened 495 new positions and closed 397 in Q2 2019.
- Jim Simons's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.